Insider Transactions Reported by 15 Insiders of Corvus Pharmaceuticals, Inc.

Symbol
CRVS on Nasdaq
Location
Burlingame, CA

Insiders trading volume in the past year

Corvus Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Peter A. Thompson Director, 10%+ Owner $29,796,393 -$4,891,894 -14% 27 Jun 2025
ORBIMED ADVISORS LLC Director, 10%+ Owner $29,796,393 -$4,891,894 -14% 27 Jun 2025
ADAMS STREET PARTNERS LLC 10%+ Owner $8,025,259 11 Aug 2022
Richard A. Miller President and CEO, Director $7,435,853 04 Dec 2025
Terry P. Gould Director, 10%+ Owner $5,670,746 13 Jun 2024
William Benton Jones SVP, Pharmaceutical Development $605,955 04 Dec 2025
EcoR1 Capital, LLC 10%+ Owner $198,639 30 Sep 2021
Jeffrey Arcara Chief Business Officer 04 Dec 2025
IAN T. CLARK Director 12 Jun 2025
Scott W. Morrison Director 12 Jun 2025
Leiv Lea Chief Financial Officer 04 Dec 2025
Linda Grais Director 12 Jun 2025
Edith P. Mitchell Director 06 Dec 2023
David Scott Moore Director 02 Oct 2025
Richard van den Broek Director 08 Apr 2025

Recent Insider Transactions by Companies or Individuals for Corvus Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.